Inhibition of cardiac Na+, K+-ATPase activity by dynorphin-A and ethylketocyclazocine

Life Sci. 1988;42(4):461-8. doi: 10.1016/0024-3205(88)90085-9.

Abstract

The effect of various opioids on Na+, K+ -ATPase partially purified from rat heart was examined. Dynorphin-A (1-13), dynorphin-A (1-17) and ethylketocyclazocine (EKC), which are k-type opiate agonists, markedly inhibited the enzyme activity in a dose-dependent manner; IC50 values were 12 microM, 21 microM and 0.38 mM, respectively. Morphine (mu-type agonist), methionine- and leucine-enkephalin (delta-type agonist) at the concentration of 1 mM did not affect the enzyme activity. The effect of dynorphin-A (1-13) and EKC was not antagonized by naloxone. Dynorphin-A (1-13) mainly decreased Vmax value without the change of Km value in the activation of Na+, K+-ATPase by ATP, Na+ and K+. Dynorphin-A(1-13) inhibited the partial reactions of Na+, K+-ATPase at the different degree of the potency; the inhibition of K+-stimulated phosphatase was greater than that of Na+-dependent phosphorylation. The present study suggests that dynorphin-A and EKC have an effect on cardiovascular system which is mediated by the inhibition of Na+, K+-ATPase in the heart.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Animals
  • Cyclazocine / analogs & derivatives*
  • Cyclazocine / pharmacology
  • Dynorphins / pharmacology*
  • Enzyme Activation / drug effects
  • Ethylketocyclazocine
  • Male
  • Myocardium / enzymology*
  • Naloxone / pharmacology
  • Peptide Fragments / pharmacology
  • Potassium / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Sodium / pharmacology
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors*

Substances

  • Peptide Fragments
  • Naloxone
  • Ethylketocyclazocine
  • dynorphin (1-13)
  • Dynorphins
  • Adenosine Triphosphate
  • Sodium
  • Sodium-Potassium-Exchanging ATPase
  • Cyclazocine
  • Potassium